Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) is a publicly traded Financial Services sector company. As of July 21, 2026, DMAA trades at $10.70 with a market cap of $259.03M and a P/E ratio of 0.00. DMAA moved +0.28% today. Year to date, DMAA is +3.29%; over the trailing twelve months it is +4.86%. Its 52-week range spans $9.95 to $10.69. Rallies surfaces DMAA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. DMAA moved +0.28% today.
| Metric | Value |
|---|---|
| Price | $10.70 |
| Market Cap | $259.03M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.69 |
| 52-Week Low | $9.95 |
| Volume | 5.31K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $5.94M |
| Gross Margin | 0.00% |
DMAA analyst coverage data. Average price target: $0.00.